Health venture capitalists had a busy year in 2022. From navigating inflationary pressures, mass tech layoffs and the continued effects of the COVID-19 pandemic on the digital health industry, investors and financiers faced a myriad of challenges.
With this in mind, many health companies were still able to raise substantial amounts of capital. Here are the 10 biggest funding rounds by health companies that Becker's covered in 2022:
- Home healthcare company DispatchHealth raised $330 million in a round led by Optum Ventures.
- Emalex, a biotech company working to develop drugs used to treat Tourette syndrome, raised $250 million in a series D round led by Bain Capital Life Sciences.
- PayZen, a healthcare payment platform, raised $220 million in a growth round comprising a financing round and credit facility. 7wireVentures led the funding, and Viola Credit provided the credit facility.
- Odyssey Therapeutics, a biotech company developing drugs used in the treatment of cancer and serious inflammatory diseases, raised $168 million in a series B round led by General Catalyst.
- Clarify Health, a cloud analytics and health value-based payments platform, raised $150 million in a series D funding round led by SoftBank Vision Fund 2.
- ClinChoice, a drug and device research company, raised $150 million in a series E funding round led by Legend Capital.
- UpStream Health, a primary care technology company, raised $140 million in a series B financing round co-led by Coatue and Dragoneer.
- CareBridge, a value-based care company, raised $140 million in a funding round led by Oak HC/FT.
- Visby Medical, a diagnostics company, raised $135 million in an oversubscribed series E funding round led by Lightrock.
- Sena Biosciences, a life sciences company, raised $123 million in a series C funding round.